Price Alert

Cyclerion Therapeutics In... (CYCN)

NASDAQ: CYCN · Real-Time Price · USD

2.22

-0.17 (-7.11%)

At close: Sep 05, 2025, 3:59 PM

2.29

3.15%

After-hours: Sep 05, 2025, 04:00 PM EDT

-7.11% (1D)

Bid	2.13
Market Cap	7.41M
Revenue (ttm)	2.17M
Net Income (ttm)	-1.95M
EPS (ttm)	-0.68
PE Ratio (ttm)	-3.26
Forward PE	-0.12
Analyst	n/a

Ask	2.45
Volume	29,376
Avg. Volume (20D)	36,858
Open	2.40
Previous Close	2.39
Day's Range	2.21 - 2.40
52-Week Range	1.27 - 9.47
Beta	1.68

About CYCN

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol CYCN

Website n/a

Full Company Profile

Why Price Moved

1 month ago

+3.58%

Cyclerion Therapeutics shares are trading lower. T... Unlock content with Pro Subscription

News

3 years ago · zacks.com

Cyclerion Therapeutics, Inc. (CYCN) Reports Q2 Loss, Misses Revenue Estimates

Cyclerion Therapeutics, Inc. (CYCN) delivered earnings and revenue surprises of 8.82% and 56.90%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the st...

3 years ago · benzinga.com

Cyclerion Neurology Candidate Shows Encouraging Action In Preclinical Studies

Cyclerion Therapeutics Inc's (NASDAQ: CYCN) preclinical studies demonstrated its lead soluble guanylate cyclase (sGC) stimulator, CY6463, improved cellular energetics and reduced inflammation in precl...